MedTrace Logo

Clinical Trials

NCT05828589 | TERMINATED | PHASE1
51 participants

A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-14
Start Date:
2023-06-20
Completion:
2026-06-08
Conditions
  • Relapsed Non-Hodgkin Lymphoma
  • Refractory Non-Hodgkin Lymphoma
  • Relapsed Chronic Lymphocytic Leukemia
  • Refractory Chronic Lymphocytic Leukemia
  • Relapsed Follicular Lymphoma
  • Relapsed Marginal Zone Lymphoma
  • Relapse Diffuse Large B Cell Lymphoma
  • Relapsed Small Lymphocytic Lymphoma
  • Refractory Follicular Lymphoma
  • Refractory Marginal Zone Lymphoma
  • Refractory Small Lymphocytic Lymphoma
  • Richter Transformation
  • Refractory Diffuse Large B-cell Lymphoma
  • Transformed Non-Hodgkin Lymphoma
Interventions
  • DRUG
No Results Yet
NCT05698693 | COMPLETED | EARLY_PHASE1
80 participants

Social Determinants of Sleep and Obesity

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-14
Start Date:
2023-11-01
Completion:
2026-07-05
Conditions
  • Insufficient Sleep
  • Physical Inactivity
  • Sedentary Behavior
  • Obesity
Interventions
  • BEHAVIORAL
No Results Yet
NCT05691465 | RECRUITING | PHASE2
35 participants

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-14
Start Date:
2023-12-27
Completion:
2026-11-02
Conditions
  • Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation
  • Metastatic Prostate Neuroendocrine Carcinoma
  • Metastatic Prostate Small Cell Neuroendocrine Carcinoma
  • Stage IVB Prostate Cancer AJCC v8
Interventions
  • PROCEDURE
  • RADIATION
  • DRUG
No Results Yet
NCT05660369 | RECRUITING | PHASE1
21 participants

CARv3-TEAM-E T Cells in Glioblastoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-14
Start Date:
2023-03-22
Completion:
2026-09-01
Conditions
  • Glioblastoma
  • Malignant Glioma
  • Recurrent Glioblastoma
  • Recurrent Glioma
Interventions
  • DRUG
No Results Yet
NCT05640271 | RECRUITING | PHASE2
200 participants

Tocilizumab for Acute Chest Syndrome

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-14
Start Date:
2023-04-10
Completion:
2026-10-31
Conditions
  • Sickle Cell Disease
  • Acute Chest Syndrome
Interventions
  • DRUG
No Results Yet
NCT05622643 | ACTIVE_NOT_RECRUITING
300 participants

OFSEP Very High Definition Cohort

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-14
Start Date:
2023-01-19
Completion:
2027-12-01
Conditions
  • Multiple Sclerosis
Interventions
  • OTHER
No Results Yet
NCT05400122 | SUSPENDED | PHASE1
12 participants

Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-14
Start Date:
2022-09-09
Completion:
2026-12-31
Conditions
  • Colorectal Cancer
  • Hematologic Malignancy
  • Rectum Cancer
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Acute Lymphoblastic Leukemia
  • Chronic Myeloid Leukemia
  • Chronic Lymphocytic Leukemia
  • Hodgkin Lymphoma
  • Non Hodgkin Lymphoma
  • Myeloproliferative Syndrome
  • Plasma Cell Myeloma
  • Gastric Cancer
  • Esophageal Cancer
  • Esophagus Cancer
  • Gastric Cancer, Metastatic
  • Unresectable Esophageal Cancer
  • Metastatic Esophageal Cancer
Interventions
  • DRUG
No Results Yet
NCT05351593 | RECRUITING | PHASE1/PHASE2
35 participants

Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-14
Start Date:
2022-06-08
Completion:
2026-12-31
Conditions
  • CNS Lymphoma
  • Primary Central Nervous System Lymphoma
  • Secondary Central Nervous System Lymphoma
Interventions
  • DRUG
No Results Yet
NCT05286801 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
86 participants

Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-14
Start Date:
2022-11-17
Completion:
2030-03-31
Conditions
  • Atypical Teratoid/Rhabdoid Tumor
  • Epithelioid Sarcoma
  • Kidney Medullary Carcinoma
  • Malignant Solid Neoplasm
  • Poorly Differentiated Chordoma
  • Recurrent Atypical Teratoid/Rhabdoid Tumor
  • Recurrent Chordoma
  • Recurrent Epithelioid Sarcoma
  • Recurrent Kidney Medullary Carcinoma
  • Recurrent Malignant Solid Neoplasm
  • Recurrent Rhabdoid Tumor
  • Refractory Atypical Teratoid/Rhabdoid Tumor
  • Refractory Chordoma
  • Refractory Epithelioid Sarcoma
  • Refractory Kidney Medullary Carcinoma
  • Refractory Malignant Solid Neoplasm
  • Refractory Rhabdoid Tumor
  • Rhabdoid Tumor
Interventions
  • BIOLOGICAL
  • PROCEDURE
  • OTHER
No Results Yet
NCT05286736 | ACTIVE_NOT_RECRUITING
50 participants

Neuroplasticity in Parkinson's Disease

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-14
Start Date:
2021-03-01
Completion:
2026-08-31
Conditions
  • Parkinson
  • Parkinson Disease
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page